Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 14, 2014; 20(30): 10249-10261
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10249
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10249
Molecular alteration | miRNAs | Clinical significance |
Down regulation | miR-139 | Poor survival[70] |
miR-26 | Shorter overall survival[82-87] | |
miR-124 | Gain of metastatic properties early recurrence[69] | |
miR-145 | Advanced tumor progression, poor prognosis[71] | |
miR-199a-3p | Reduced time to recurrence[72] | |
miR-199b-5p | Poor overall survival and Progression-free survival rates[72] | |
miR-122 | Poor prognosis[82-87] | |
Up regulation | miR-222 | Shorter disease-free survival[73] |
miR--135 | Poor prognosis worse Edmondson-Steiner grade, vein invasion, shortened overall survival and disease-free survival[74] | |
miR-221 | Multinodularity, reduced time to recurrence, gain of metastatic properties high tumor capsular infiltration[79] | |
miR--155 | Poorer recurrence-free survival and overall survival[75] | |
miR--182 | Intrahepatic metastasis and poor prognosis[76] | |
miR- 10b | Poor prognosis[77] | |
miR-17-5p | Poor prognosis[78] | |
miR-21 | Poor prognosis[79] |
- Citation: Han LL, Lv Y, Guo H, Ruan ZP, Nan KJ. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy. World J Gastroenterol 2014; 20(30): 10249-10261
- URL: https://www.wjgnet.com/1007-9327/full/v20/i30/10249.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i30.10249